179 related articles for article (PubMed ID: 31557321)
1. EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.
Gaucher S; Lwin SM; Titeux M; Abdul-Wahab A; Pironon N; Izmiryan A; Miskinyte S; Ganier C; Duchatelet S; Mellerio JE; Bourrat E; McGrath JA; Hovnanian A
Br J Dermatol; 2020 Mar; 182(3):794-797. PubMed ID: 31557321
[No Abstract] [Full Text] [Related]
2. Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT).
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):65-6. PubMed ID: 24933565
[No Abstract] [Full Text] [Related]
3. Gene therapy for recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Hovnanian A
Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
[TBL] [Abstract][Full Text] [Related]
4. siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.
Pendaries V; Gasc G; Titeux M; Tonasso L; Mejía JE; Hovnanian A
J Invest Dermatol; 2012 Jun; 132(6):1741-3. PubMed ID: 22336946
[No Abstract] [Full Text] [Related]
5. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
6. Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
Woodley DT; Chen M
J Invest Dermatol; 2015 Jul; 135(7):1705-1707. PubMed ID: 26066885
[No Abstract] [Full Text] [Related]
7. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
Perdoni C; Osborn MJ; Tolar J
Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
[TBL] [Abstract][Full Text] [Related]
8. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa.
Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W
Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059
[No Abstract] [Full Text] [Related]
9. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.
Varki R; Sadowski S; Uitto J; Pfendner E
J Med Genet; 2007 Mar; 44(3):181-92. PubMed ID: 16971478
[TBL] [Abstract][Full Text] [Related]
11. A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa.
Morgan CP; Allen DSI; Millington-Ward S; O'Dwyer GE; Palfi A; Jane Farrar G
J Invest Dermatol; 2013 Dec; 133(12):2793-2796. PubMed ID: 23743647
[No Abstract] [Full Text] [Related]
12. Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa within the same family: two phenotypes associated with a COL7A1 mutation.
Murase K; Kanoh H; Ishii N; Hashimoto T; Nakano H; Sawamura D; Seishima M
Acta Derm Venereol; 2011 Oct; 91(6):730-1. PubMed ID: 21629976
[No Abstract] [Full Text] [Related]
13. Identification of mutations in the COL7A1 gene in a proband with mild recessive dystrophic epidermolysis bullosa and aortic insufficiency.
Horev L; Waran Lalin T; Martinez-Mir A; Bagheri BA; Tadin-Strapps M; Schneiderman PI; Grossman ME; Bickers DR; Christiano AM
Clin Exp Dermatol; 2003 Jan; 28(1):80-4. PubMed ID: 12558638
[TBL] [Abstract][Full Text] [Related]
14. Revertant mosaicism in recessive dystrophic epidermolysis bullosa.
Almaani N; Nagy N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Clements SE; Techanukul T; Tanaka A; Mellerio JE; McGrath JA
J Invest Dermatol; 2010 Jul; 130(7):1937-40. PubMed ID: 20357813
[No Abstract] [Full Text] [Related]
15. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
[TBL] [Abstract][Full Text] [Related]
16. Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.
Tovar Vetencourt A; Sayed-Ahmed I; Gomez J; Chen H; Agostini B; Carroll K; Parry T; Krishnan S; Sabater AL
N Engl J Med; 2024 Feb; 390(6):530-535. PubMed ID: 38324486
[TBL] [Abstract][Full Text] [Related]
17. A case of recessive dystrophic epidermolysis bullosa with a novel c.6885_6898del14 mutation in the COL7A1 gene.
Shinkuma S; Masunaga T; Miyawaki S; Takashima S; Natsuga K; Nomura T; Fujita Y; Nakamura H; Shimizu H
J Dermatol Sci; 2017 Oct; 88(1):139-141. PubMed ID: 28427821
[No Abstract] [Full Text] [Related]
18. Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.
Weinel S; Lucky AW; Uitto J; Pfendner EG; Choo D
Pediatr Dermatol; 2008; 25(2):210-4. PubMed ID: 18429782
[TBL] [Abstract][Full Text] [Related]
19. A novel insertion mutation in COL7A1 identified in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa.
Sato-Matsumura KC; Sawamura D; Goto M; Goto M; Nakamura H; Shimizu H
Acta Derm Venereol; 2003; 83(2):137-8. PubMed ID: 12735646
[No Abstract] [Full Text] [Related]
20. Innovative therapeutic strategies for recessive dystrophic epidermolysis bullosa.
Larcher F; Del Río M
Actas Dermosifiliogr; 2015 Jun; 106(5):376-82. PubMed ID: 25796272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
